Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06313697
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-03-05
Brief Title:
A Study to Evaluate the Safety Immunogenicity and Pharmacokinetics of GR2102 in Healthy Adult
Sponsor:
Genrix Shanghai Biopharmaceutical Co Ltd
Organization:
Genrix Shanghai Biopharmaceutical Co Ltd
Organization Data
Organization:
Genrix Shanghai Biopharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
GR2102-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genrix Shanghai Biopharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None